Aleksandr Eygurin

Aleksandr Eygurin has a diverse work experience in the pharmaceutical sales industry, spanning over two decades. Aleksandr started their career as a Sales Representative at Tamro Corporation in 1994, where they successfully expanded the company's presence in St. Petersburg and developed relationships with 150 customers. Aleksandr then progressed to the role of Regional Sales Manager at Tamro Corporation in St. Petersburg, Russia in 1997, where they led the expansion of the sales staff in the North-Western region of Russia, planned market penetration strategies, and significantly increased the company's sales by $400,000 per month.

In 2003, Eygurin joined Procter & Gamble as a Pharmaceutical Sales Representative, where they focused on the East of Brooklyn market. During their six-year tenure, Eygurin successfully increased the market share of multiple products, developed relationships with over 300 customers, and launched several new products, including Actonel with calcium, Actonel 150mg, Enablex, and Asacol HD. Aleksandr received five President Club awards for their exceptional performance, placing him among the top 5% of sales representatives.

Eygurin then transitioned to Warner Chilcott in 2009, first as a Senior Pharmaceutical Sales Representative, and later as a Specialty Pharmaceutical Sales Representative in the Women's Healthcare Division. In these roles, they launched a new product called Atelvia 35mg in the East of Brooklyn, implemented strategies to increase market share, and achieved impressive growth of 17% NRX over one year. Eygurin consistently performed exceptionally, ranking among the top representatives in the country for osteoporosis sales, winning multiple sales contests, and achieving high rankings within the company.

Following their time at Warner Chilcott, Eygurin joined Pfizer in 2014 as a Specialty Pharmaceutical Sales Representative in the Women's Healthcare Division. Their responsibilities included launching and promoting the new product Duavee 0.45/20mm in Brooklyn/Queens. Eygurin successfully developed and executed a strategy that resulted in a 6.5% NRX growth within one year.

In 2015, Eygurin moved on to Depomed, Inc., where they served as a Specialty Pharmaceutical Sales Representative in the Pain Division. During their tenure, they played a crucial role in promoting pain products and achieved notable sales results.

Most recently, Eygurin worked at Assertio Therapeutics, Inc. as a Senior Specialty Pharmaceutical Sales Representative, starting in 2018. Aleksandr focused on selling specialty pharmaceuticals and showcased their expertise in this field until 2020.

Currently, Eygurin holds the position of Neuroscience Account Manager at SK Life Science, Inc. since February 2020.

Aleksandr Eygurin completed their Bachelor's degree in Mechanical Engineering from Baltic State Technical University "VOENMEH" named after D.F. Ustinov from 1987 to 1993. Aleksandr then pursued further education and obtained a Master of Science (MS) degree in Pharmaceutical Marketing and Management from INACTIVE-1703030558-LIU Brooklyn, attending from 2000 to 2003.